TY  - CHAP
M1  - Book, Section
TI  - Fatigue & Systemic Intolerance Disease (Chronic Fatigue Syndrome)
A1  - Nadler, Paul L.
A1  - Gonzales, Ralph
A2  - Papadakis, Maxine A.
A2  - McPhee, Stephen J.
A2  - Rabow, Michael W.
A2  - McQuaid, Kenneth R.
PY  - 2023
T2  - Current Medical Diagnosis & Treatment 2023
AB  - Key  Clinical  Updates  in  Fatigue  &  Systemic  Intolerance  Disease  (Chronic  Fatigue  Syndrome)Pitolisant,  a  selective  histamine  H3  receptor  antagonist  with  wake-promoting  effect,  may  reduce  daytime  sleepiness  in  patients  with  moderate  to  severe  obstructive  sleep  apnea  who  do  not  want  continuous  positive  airway  pressure  treatment.Dauvilliers  Y  et  al.  Am  J  Respir  Crit  Care  Med.  [PMID:  31917607]  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/19
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1193124279
ER  -